Calendar Merck & Co., Inc.

Equities

MRK

US58933Y1055

Market Closed - Nyse 04:01:04 2024-03-18 pm EDT 5-day change 1st Jan Change
121.4 USD -0.07% Intraday chart for Merck & Co., Inc. -1.08% +11.39%

Chart calendar Merck & Co., Inc.

61a002f252e18.DD2XysDTALMUlLKSf-5L5O-LeG7AGAkvFpODhyVZTWs.flXgnKKVZOV9-4PoOtYYhdu_HRSseUBBVfz20mJueApneMKigut55GXd1Q~92f8cb85f617cbbc832fef8890219d30

Upcoming events on Merck & Co., Inc.

2024-04-25 06:30 am Q1 2024 Earnings Release
2024-04-25 09:00 am Q1 2024 Earnings Call
2024-05-17 Annual General Meeting
2024-07-30 06:30 am Q2 2024 Earnings Release
2024-07-30 09:00 am Q2 2024 Earnings Call
2024-10-31 06:30 am Q3 2024 Earnings Release
2024-10-31 09:00 am Q3 2024 Earnings Call
2025-01-29 Q4 2024 Earnings Release (Projected)
2025-04-23 Q1 2025 Earnings Release (Projected)
2025-08-04 Q2 2025 Earnings Release (Projected)
2025-10-22 Q3 2025 Earnings Release (Projected)

Past events on Merck & Co., Inc.

2024-03-13 Ex-dividend day
2024-03-12 03:05 pm Barclays Global Healthcare Conference
2024-03-11 12:40 pm Leerink Partners Global Biopharma Conference
2024-03-05 01:30 pm TD Cowen Health Care Conference
2024-02-01 09:00 am Q4 2023 Earnings Call
2024-02-01 06:30 am Q4 2023 Earnings Release
2024-01-25 American Society of Clinical Oncology Genitourinary Cancers Symposium - Abstract No : #LBA531
2024-01-08 07:30 pm JPMorgan Healthcare Conference
2024-01-04 12:45 pm Goldman Sachs Healthcare C-Suite Unscripted Conference
2023-12-13 Ex-dividend day
2023-12-06 European Society for Medical Oncology Immuno Oncology Congress - Abstract No:121P
2023-11-30 01:20 pm Evercore ISI HealthCONx Conference
2023-11-16 05:00 am Jefferies London Healthcare Conference
2023-11-08 12:00 pm UBS BioPharma Conference
2023-10-26 09:00 am Q3 2023 Earnings Call
2023-10-26 06:30 am Q3 2023 Earnings Release
2023-10-22 01:00 pm European Society for Medical Oncology Congress
2023-10-20 10:15 am European Society for Medical Oncology Congress - Abstract No. - #LBA38
2023-10-19 European Society for Medical Oncology Congress - Abstract No. - #LBA48
2023-10-19 European Society for Medical Oncology Congress - Abstract No. -#663P

Past dividends on Merck & Co., Inc.

2024-03-13 Quarterly 0.77 USD
2023-12-13 Quarterly 0.77 USD
2023-09-13 Quarterly 0.73 USD
2023-06-13 Quarterly 0.73 USD
2023-03-13 Quarterly 0.73 USD
2022-12-13 Quarterly 0.73 USD
2022-09-13 Quarterly 0.69 USD
2022-06-13 Quarterly 0.69 USD
2022-03-13 Quarterly 0.69 USD
2021-12-13 Quarterly 0.69 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
46 840
46 818
0.05%
47 994
48 177
-0.38%
48 704
48 367
0.7%
59 283
59 144
0.24%
60 115
59 938
0.3%

63 744

EBITDA
Million USD
Released
Forecast
Spread
19 572
18 761
4.32%
20 570
19 815
3.81%
20 910
19 760
5.82%
26 431
24 588
7.5%
10 083
9 362
7.71%

29 074

EBIT
Million USD
Released
Forecast
Spread
15 920
16 276
-2.19%
16 945
17 366
-2.43%
17 696
17 554
0.81%
22 522
22 363
0.71%
6 211
6 066
2.4%

25 868

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
11 464
12 277
-6.62%
8 791
14 906
-41.02%
13 879
12 048
15.2%
16 444
17 389
-5.44%
1 889
2 857
-33.89%

24 091

Net income
Million USD
Released
Forecast
Spread
9 843
9 957
-1.15%
7 067
12 094
-41.57%
13 049
11 797
10.61%
14 519
14 827
-2.07%
365
1 682
-78.3%

19 921

EPS
USD
Released
Forecast
Spread
3,81
3,83
-0.52%
2,78
4,71
-41%
5,14
4,70
9.39%
5,71
5,87
-2.73%
0,14
0,56
-75.16%

7,87

Announcement Date05/02/2004/02/2103/02/2202/02/2301/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
13 521
13 212
2.34%
15 901
14 648
8.55%
14 593
13 861
5.28%
14 959
14 043
6.52%
13 830
13 676
1.12%
14 487
13 799
4.98%
15 035
14 450
4.05%
15 962
15 273
4.51%
14 630
14 480
1.03%

15 174


15 850


16 628


16 033


15 908

EBITDA
Million USD
Released
Forecast
Spread
5 670
4 892
15.91%
7 568
5 918
27.88%
6 649
6 064
9.65%
6 516
6 275
3.85%
5 698
5 183
9.94%
5 402
5 058
6.8%
-3 485
-3 901
10.67%
7 538
6 724
12.1%
665
1 985
-66.49%

6 837


6 435


7 731


6 893




EBIT
Million USD
Released
Forecast
Spread
4 835
4 528
6.79%
6 448
5 393
19.56%
5 711
5 157
10.75%
5 557
5 268
5.49%
4 806
4 592
4.66%
4 411
4 088
7.89%
-4 388
-4 683
6.29%
6 524
5 967
9.33%
-299
-476
37.23%

6 222


6 145


7 101


6 229




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread









3 583
3 956
-9.43%
3 513
3 391
3.6%
3 650
4 190
-12.89%
-5 335
-4 682
-13.95%
5 620
5 023
11.89%
-2 046
-1 249
-63.78%

5 844


5 544


6 250


5 861




Net income
Million USD
Released
Forecast
Spread
3 758
3 557
5.64%
4 310
3 768
14.4%
3 944
3 859
2.19%
3 248
3 477
-6.6%
3 017
3 016
0.02%
2 821
3 133
-9.97%
-5 975
-6 154
2.9%
4 745
4 224
12.34%
-1 226
-919
-33.43%

4 588


4 772


5 420


4 683




EPS
USD
Released
Forecast
Spread
1,48
1,35
9.77%
1,70
1,48
14.96%
1,55
1,48
4.46%
1,28
1,42
-10.11%
1,18
1,20
-1.99%
1,11
1,21
-8.14%
-2,35
-2,44
3.61%
1,86
1,65
12.59%
-0,48
-0,35
-37.91%

1,84


1,87


2,15


1,87




Announcement Date03/02/2228/04/2228/07/2227/10/2202/02/2327/04/2301/08/2326/10/2301/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Merck & Co., Inc. - Nyse
  4. Calendar Merck & Co., Inc.